ACCP collaborates with ASHP on Geriatric Pharmacy activities.

ASHP members, please visit www.rxcertifications.org to receive member pricing.

• Series Overview
• Program Content
• Faculty and Reviewers
• Financial Relationship Disclosures
• Target Audience and Learning Objectives
• Continuing Pharmacy Education Credit
• Specialty Recertification Credit
• Technical Requirements
• Commercial Support
• Fees

The 2022 ACCP/ASHP BCGP Clinical Sessions are part of the professional development programs for recertification of the Board Certified Geriatric Pharmacist and/or the Board Certified Ambulatory Care Pharmacist approved by the Board of Pharmacy Specialties (BPS) and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP).

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants' skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Release date: December 14, 2022
Specialty Recertification credit expiration date: December 12, 2023
ACPE credit expiration date: December 14, 2025

The 2022 ACCP/ASHP BCGP Clinical Sessions are offered in four presentations. Each presentation focuses on a different Geriatric Pharmacy/Ambulatory Care Pharmacy topic that is highly relevant for day-to-day practice. Topics include minimizing fall risk, sleep disorders in older adults, Heart Failure with preserved Ejection Fraction (HFpEF), and treatment of Alzheimer’s and Parkinson’s.

BCGP Clinical Session
Watch Your Step! Navigating Polypharmacy to Minimize Fall Risk
This session will provide participants with fall prevention strategies and tools they can use in their clinical practice. Examples of fall prevention clinics and services will be provided as well as a dive into the literature regarding medications that increase the risk of falls. Furthermore, strategies for reducing use of these medications such as example tapering regimens will be offered as well. After this session, participants will be equipped to be proactive in their approach to fall prevention rather than reactive.

BCACP/BCGP Clinical Session
Sweet Dream or Nightmare: Managing Sleep Complaints in Older Adults
The purpose of this session will be to review management strategies of common sleep complaints, examine newer literature in the arena and apply the guidance to clinical pharmacy practice. Insomnia continues to be a common health issue for older adults with the patient population being extremely prone to medication related problems. Obstructive sleep apnea (OSA) and restless leg syndrome (RLS) can both be complicating factors for a patient's insomnia and excessive daytime sleepiness. New guidelines published on RLS management now recommend alpha2-delta calcium channel ligands over dopamine agonists for first line treatment of chronic RLS. OSA continues to be a contributor to underlying chronic disease states such as hypertension and is frequently under documented on a patient's problem list. Participants will be empowered to tackle this potential nightmare in practice through evidence-based approaches.

BCACP/BCGP Clinical Session
Anything ARNI Can Do, SGLT2i Can Do Better? Debate of Pharmacologic Therapies in HFpEF
Heart Failure with preserved Ejection Fraction (HFpEF) affects between 1.1-5.5% of the general population, with a prevalence of > 10% in older adults (> 75 years of age). Patients with HFpEF suffer from significant morbidity and mortality, however traditional therapies used to manage Heart Failure with reduced Ejection Fraction (HFrEF), have failed to reduce morbidity or mortality in these patients. Recently, mineralocorticoid receptor antagonists (MRA), sodium-glucose cotransporter 2 (SGLT2) inhibitors, and angiotensin receptor blocker neprilysin inhibitors (ARNI) have demonstrated benefits in this population, but limitations in data pose questions regarding application to routine patient care. Further understanding related to patient selection, safe initiation and monitoring, and considerations for shared-decision making discussions (e.g., cost and adherence) is important for adequate therapy optimization, particularly in ambulatory settings and with older adult patients. This session will discuss an initial overview of HFpEF, the "traditional" approach to management, and gaps in patient care; a discussion of recently evaluated entities for HFpEF, including MRA, ARNI and SGLT2 inhibitors; and a case-based format.

BCACP/BCGP Clinical Session
Breaking Down Neurodegenerative Diseases: Pharmacy Updates in Managing Alzheimer's and Parkinson's
More than 6 million Americans are living with Alzheimer’s disease (AD) and another 1 million are living with Parkinson’s disease (PD). Advances have been made in the management of both illnesses; however, models suggest there may be barriers to their practical use. This session will address AD immunotherapies on the breakthrough pathway, focusing on the appropriate use of approved therapies, expectations for emerging therapies, potential barriers to use and subsequent place in therapy. The role of the pharmacist in closing gaps in screening, diagnosis, and treatment for AD will be emphasized. Furthermore, the session will address the place in therapy for new medications and formulations approved to treat motor, non-motor, and psychiatric complications of PD.

Watch Your Step! Navigating Polypharmacy to Minimize Fall Risk

	Danielle Fixen, Pharm.D., BCGP Associate Professor University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora, Colorado

Sweet Dream or Nightmare: Managing Sleep Complaints in Older Adults

	Laura A. Schalliol, Pharm.D., BCACP, BCGP Associate Professor of Pharmacy Practice PGY-1 Community-Based Residency Program Director South College School of Pharmacy Knoxville, Tennessee
	Kimberly Zitko, Pharm.D., BCACP, BCGP Assistant Professor of Pharmacy Practice South College School of Pharmacy Knoxville, Tennessee

Anything ARNI Can Do, SGLT2i Can Do Better? Debate of Pharmacologic Therapies in HFpEF

	Stormi Gale, Pharm.D., BCCP, BCPS Clinical Pharmacist, Cardiology Subject Matter Expert Novant Health Matthews Medical Center Matthews, North Carolina
	Alina Kukin, Pharm.D., BCCP Cardiology Clinical Pharmacy Specialist Hospital of the University of Pennsylvania Philadelphia, Pennsylvania
	Tracy E. Macaulay, Pharm.D., BCPS Clinical Pharmacist Specialist, Cardiology Gill Heart Institute University of Kentucky Lexington, Kentucky

Breaking Down Neurodegenerative Diseases: Pharmacy Updates in Managing Alzheimer's and Parkinson's

	Jenelle H. Montgomery, Pharm.D., BCACP, CPP Clinical Pharmacist Practitioner Duke University Hospital Assistant Professor of Clinical Education UNC Eshelman School of Pharmacy Durham, North Carolina
	Kristin Zimmerman, Pharm.D., CGP Associate Professor, Department of Pharmacotherapy and Outcomes Science VCU School of Pharmacy Richmond, Virginia

• Amie Blaszczyk, Pharm.D., BCGP, BCPS, FASCP
• Holly L. Byrnes, Pharm D., BCPS
• Dana G. Carroll, Pharm.D.
• Rebecca Cope, Pharm.D., MPH, BCACP
• Michelle L. Hilaire, Pharm.D., FCCP, BCPS, BCACP, CDE
• Kristi Hofer, Pharm.D.
• Nicholas Leon, Pharm.D., BCACP, BCPS, FCPP
• Lindsay M. Saum, Pharm.D., BCPS, BCGP
• Maria Shin, Pharm.D., BCGP, BCPS

Disclosures 

Target Audience
These recertification activities are intended for the Board Certified Geriatric Pharmacist (BCGP) and the Board Certified Ambulatory Care Pharmacist (BCACP) and those interested in minimizing fall risk, sleep disorders in older adults, Heart Failure with preserved Ejection Fraction (HFpEF), and treatment of Alzheimer's and Parkinson's.

Learning Objectives
Learning Objectives 

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

BCGP Clinical Session
Watch Your Step! Navigating Polypharmacy to Minimize Fall Risk
Activity Number: 0204-9999-22-302-H01-P
Contact Hours: 1.00
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
Sweet Dream or Nightmare: Managing Sleep Complaints in Older Adults
Activity Number: 0217-9999-22-068-H01-P
Contact Hours: 1.00
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
Anything ARNI Can Do, SGLT2i Can Do Better? Debate of Pharmacologic Therapies in HFpEF
Activity Number: 0204-9999-22-331-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
Breaking Down Neurodegenerative Diseases: Pharmacy Updates in Managing Alzheimer's and Parkinson's
Activity Number: 0204-9999-22-287-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

Methods and CE Requirements

Continuing Pharmacy Education Credit

To be eligible to earn continuing pharmacy education credit, learners must purchase the product, review all content, successfully complete, submit and pass the web-based posttest associated with each module within the course by December 14, 2025. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

   

To be eligible to earn BCGP and BCACP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by December 12, 2023. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

The passing point to earn BCGP and BCACP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the Specialty Recertification Credit posttest deadline that meets this passing point will earn BCGP and BCACP recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCGP or BCACP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.

• Internet browser
• Adobe Reader (available free)

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.